Association of Conformational High-dose Radiotherapy and of Hyperselective Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma

Study ID
NCT01300143

Study type
Interventional

Study phase
Phase 2

Study status
Completed

Trial Acronym

TACERTE

Trial Summary

Indication : Hepatocellular carcinoma, maximum size 9 cm, with single or multiple nodes whose total tumor mass can technically be irradiated, non-resectable, and not a candidate for percutaneous therapy with recommended treatment via hyperselective transarterial chemoembolisation (TACE).

More informations

Trial Starting Date

Jun 30,2011

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit

126